KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $141.98 $159.34 Friday, 26th Apr 2024 ALNY stock ended at $143.31. This is 0.278% less than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 2.14% from a day low at $143.00 to a day high of $146.07.
90 days $141.98 $181.66
52 weeks $141.98 $218.88

Historical Alnylam Pharmaceuticals prices

Date Open High Low Close Volume
Apr 12, 2016 $67.43 $67.43 $67.43 $67.43 800 894
Apr 11, 2016 $66.77 $66.77 $66.77 $66.77 1 056 850
Apr 08, 2016 $69.15 $69.15 $69.15 $69.15 1 086 935
Apr 07, 2016 $71.74 $71.74 $71.74 $71.74 1 760 463
Apr 06, 2016 $73.00 $73.00 $73.00 $73.00 977 883
Apr 05, 2016 $68.33 $68.33 $68.33 $68.33 1 306 731
Apr 04, 2016 $67.54 $67.54 $67.54 $67.54 1 238 874
Apr 01, 2016 $64.79 $64.79 $64.79 $64.79 749 072
Mar 31, 2016 $62.77 $62.77 $62.77 $62.77 982 794
Mar 30, 2016 $59.57 $59.57 $59.57 $59.57 552 145
Mar 29, 2016 $59.84 $59.84 $59.84 $59.84 897 100
Mar 28, 2016 $58.78 $58.78 $58.78 $58.78 697 400
Mar 24, 2016 $60.28 $60.28 $60.28 $60.28 698 900
Mar 23, 2016 $59.06 $59.06 $59.06 $59.06 708 800
Mar 22, 2016 $62.22 $62.22 $62.22 $62.22 1 189 300
Mar 21, 2016 $61.31 $61.31 $61.31 $61.31 794 400
Mar 18, 2016 $59.80 $59.80 $59.80 $59.80 1 314 800
Mar 17, 2016 $57.84 $57.84 $57.84 $57.84 981 800
Mar 16, 2016 $60.39 $60.39 $60.39 $60.39 870 700
Mar 15, 2016 $61.70 $61.70 $61.70 $61.70 1 065 000
Mar 14, 2016 $65.77 $65.77 $65.77 $65.77 1 657 400
Mar 11, 2016 $62.15 $62.15 $62.15 $62.15 1 931 700
Mar 10, 2016 $58.09 $58.09 $58.09 $58.09 1 039 400
Mar 09, 2016 $60.12 $60.12 $60.12 $60.12 1 265 900
Mar 08, 2016 $57.53 $57.53 $57.53 $57.53 790 100
Click to get the best stock tips daily for free!

About Alnylam Pharmaceuticals

Alnylam Pharmaceuticals Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system (CNS)/ocular diseases. Its marketed products include ONPATTRO (patisiran), a lipid complex injection f... ALNY Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT